| Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224) |
|---|
| 01/20/2004 | CA2303498C Dioxocyclopentyl hydroxamic acids |
| 01/15/2004 | WO2004005513A2 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 01/15/2004 | WO2004004703A1 m-PHENYLENEDIAMINE DERIVATIVE |
| 01/15/2004 | WO2004004657A2 Hiv integrase inhibitors |
| 01/15/2004 | US20040010149 Ligand for transition metal complex catalyst |
| 01/15/2004 | CA2490579A1 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 01/14/2004 | EP1380562A1 Carboxylic acid derivative and salt thereof |
| 01/14/2004 | EP1379498A1 Sulphones which modulate the action of gamma secretase |
| 01/14/2004 | CN1468227A Non-imidazole aryloxyalkylamines |
| 01/14/2004 | CN1468221A Non-imidazole aryloxypiperidines |
| 01/14/2004 | CN1468214A Novel derivatives of aminocyclohexane |
| 01/14/2004 | CN1134411C Bicyclic amino derivatives and PGD2 antagonist containing same |
| 01/13/2004 | US6677488 Substituted biphenyl compounds for the treatment of inflammation |
| 01/13/2004 | US6677365 Antagonists of MCP-1 function and methods of use thereof |
| 01/13/2004 | US6677336 Substituted piperazine compounds |
| 01/08/2004 | WO2004002977A1 Inhibitors of hcv ns5b polymerase |
| 01/08/2004 | WO2003077828A3 Novel florfenicol-type antibiotics |
| 01/08/2004 | WO2002079148A3 Multifunctional carbonates and derivatives |
| 01/08/2004 | WO2002053522A3 Novel estrogen receptor ligands and methods i |
| 01/08/2004 | US20040006130 For therapy of osteoporosis, hypoparathyreosis, osteosarcoma, periodontal disease, bone fracture, steoarthrosis, chronic rheumatoid arthritis, Paget's disease, humoral hypercalcemia, autosomal dominant hypocalcemia |
| 01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
| 01/08/2004 | CA2489433A1 Inhibitors of hcv ns5b polymerase |
| 01/07/2004 | EP1378508A1 Various forms of paroxetine hydrochloride anhydrate |
| 01/07/2004 | EP1377571A1 Compounds for use in the treatment of skin conditions |
| 01/07/2004 | CN1466569A Novel 3-substituted urea derivatives and medicinal use thereof |
| 01/06/2004 | US6673937 Analogs of deoxypreussomerin, palmarumycin cpi and related naphthoquinone spiroketals; inhibit thioredoxin-thioredoxin reductase system |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673212 Of alkylene carbonate; by-product inhibition |
| 01/02/2004 | EP1375492A1 Process for producing (dioxolenon-4-yl)methyl ester derivative |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373199A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 01/02/2004 | EP1373195A2 Quaternary amino acids on solid supports |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373170A1 Cross-metathesis reaction of functionalized and substituted olefins using group 8 transition metal carbene complexes as metathesis catalysts |
| 01/02/2004 | EP1175379B1 Method for the asymmetric dihydroxylation of olefins, using osmium catalysts |
| 01/02/2004 | EP1140799B1 Novel propargylether derivatives |
| 01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002463 Inhibitors and methods of use thereof |
| 12/31/2003 | WO2004000793A2 Aminoacetonitrile derivatives suitable for controlling parasites |
| 12/31/2003 | WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/31/2003 | WO2004000779A1 Process for producing phenyloxocarboxylic ester derivative |
| 12/31/2003 | WO2002060378A3 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 12/31/2003 | CN1463971A Process for preparing safrole by catalysis hydrogenation |
| 12/31/2003 | CA2489842A1 Aminoacetonitrile derivatives suitable for controlling parasites |
| 12/31/2003 | CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators |
| 12/30/2003 | US6670489 Process for producing cyclic formal |
| 12/30/2003 | US6670473 Inhibitors of nitric oxide synthase (nos) |
| 12/30/2003 | US6670385 α-phenyl-βketosulfone |
| 12/30/2003 | CA2051399C Therapeutically useful 2-aminotetralin derivatives |
| 12/25/2003 | US20030236406 Amination forming a benzylammonium methyl phenoxy 5-tetrahydrobenzothiepine; apical sodium co- dependent bile acid transporter inhibitors, anticholesterol agents |
| 12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
| 12/25/2003 | US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor |
| 12/25/2003 | US20030236250 Antidepressants, anxiolytic agents, analgesics, antiinflammatory agents, reduce concentration of tachykinins |
| 12/25/2003 | US20030235853 Solid phase synthesis; for drug screening |
| 12/24/2003 | WO2003019697A3 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 12/24/2003 | CN1463263A Method to inhibit ethylene responses in plants |
| 12/23/2003 | US6667342 Benzenesulfonamide-derivatives and their use as medicaments |
| 12/23/2003 | US6667307 HIV protease |
| 12/18/2003 | WO2003103656A1 O-substituted hydroxyaryl derivatives |
| 12/18/2003 | WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors |
| 12/18/2003 | US20030232985 For therapy of Alzheimer's disease and Down's Syndrome |
| 12/18/2003 | US20030232807 Dietetic agents |
| 12/18/2003 | US20030232802 Aryl and heteroaryl sulfonates |
| 12/18/2003 | US20030232789 Salicylamides as serine protease and factor xa inhibitors |
| 12/18/2003 | US20030230737 A tetrafluoroethane-dicyclohexyl ester derivatives, electrooptical displays |
| 12/17/2003 | EP1370520A1 Aryl and biaryl compounds having mch modulatory activity |
| 12/17/2003 | EP1370510A2 Hiv integrase inhibitors |
| 12/17/2003 | EP1206467B1 N-heterocyclic derivatives as nos inhibitors |
| 12/17/2003 | EP1140894B1 Process for the synthesis of 5-(alpha -hydroxyalkyl) benzo 1, 3]dioxols |
| 12/17/2003 | CN1131202C Calcium receptor-active compounds |
| 12/16/2003 | US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue |
| 12/16/2003 | CA2275299C Indane or dihydroindole derivatives |
| 12/11/2003 | WO2003102536A2 Destructible surfactants and uses thereof |
| 12/11/2003 | WO2003101941A2 Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| 12/11/2003 | WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 12/11/2003 | US20030229132 Small molecule modulators of apoptosis |
| 12/10/2003 | EP1368305A1 7, 9-substituted tetracycline compounds |
| 12/10/2003 | EP1280790B1 Use of cyclic ketals as a fragrance |
| 12/10/2003 | EP1129120B1 Modified polyisocyanates |
| 12/10/2003 | EP0933346B1 NOVEL p-TERPHENYL COMPOUNDS |
| 12/09/2003 | US6660756 Protease inhibitors; sexual disorders |
| 12/09/2003 | US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer |
| 12/04/2003 | WO2003099776A1 Calcium receptor modulating arylalkylamines |
| 12/04/2003 | WO2003099772A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 12/04/2003 | WO2003099202A2 Beta-secretase inhibitors |
| 12/04/2003 | WO2003099192A2 Bis-aromatic alkanols |
| 12/04/2003 | WO2003057169A3 4-dedimethylamino tetracycline compounds |
| 12/04/2003 | WO2003024946A3 Oxamate derivatives containing a variously substituted nitrogen heterocycle |
| 12/04/2003 | US20030225302 Aromatic amides, their preparation process and their use as pesticides |
| 12/04/2003 | US20030225266 N-aromatic or heteroaromatic-oxyalkylene, hydrocarbylnamide derivatives useful for potentiating glutamate receptor function; Alzheimer's Disease; antidepressants; cognition activators; psychosis; psychiatric and neurological disorders |
| 12/04/2003 | US20030225080 Treating a disorder responsive to the blockade of sodium channels |
| 12/04/2003 | US20030225059 Cyclohexyl derivatives and their use as therapeutic agents |
| 12/04/2003 | CA2486853A1 Bis-aromatic alkanols |
| 12/03/2003 | EP1367056A1 Drugs that enhance synaptic responses mediated by AMPA receptors |
| 12/03/2003 | EP1366041A1 Preparation of n-methylparoxetine and related intermediate compounds |
| 12/03/2003 | CN1129594C Method for continuously producing cyclic formal |
| 12/03/2003 | CN1129428C Endothelin receptor antagonists |
| 12/02/2003 | US6656954 Such as N-hydroxy-2-(((4-phenoxyphenyl)-sulfonyl)methyl) benzamide which inhibits matrix metalloprotease activity |